Based on earlier studies, this approach selects people with type 1 diabetes while excluding virtually all those with type 2 diabetes [37, 38], although there might be some severely ill type 2 diabetes patients whose poor renal function limits their diabetes medication to insulin only. This evidence concerns the gene INS and type 2 diabetes mellitus.